3D InSight™ 14 Day Hepatoxicity Testing
Product category: In vitro assays
Product code: SP-02-019-01
3D InSight™ 14 Day Hepatoxicity Testing – ATP (DILI Service)
Assesses effect of compounds on cellular viability in 3D InSight™ Human Liver Microtissues using an ATP assay endpoint.
Standard service includes: 7-point dose response curve, 7- or 14-day repeat dose protocol, cell viability endpoint, and a service summary report.
Turnaround time: 3-4 weeks.
Vendor: InSphero AG
SaferWorldbyDesign integrates in silico and in vitro methods to develop standard and premium Integrated Approaches to Testing and Assessment (IATAs), including methods that support ingredient and formulation screening and testing, product design and the preparation of Regulatory Dossiers.
Edelweiss Connect GmbH is registered as a limited company with Handelsregisteramt of Kanton Basel-Stadt
Swiss ID (UID) number: CHE-114.414.615
Copyright | SaferWorldbyDesign 2023